Supplementary Data S1 from Early [18F]FDG PET/CT Response after a Single Dose of Anti-EGFR Therapy as a Predictive Biomarker for Treatment Benefit in Patients with Advanced Colorectal Cancer

2026 Open access

Read full text
Authors: Sophie L. Gerritse, Erik Jacobus Van Helden, Anne I.J. Arens, Ronald Boellaard, Tineke E. Buffart, Mariëtte Labots, Lindsay Angus, Elisabeth G.E. de Vries, Derk Jan A. de Groot, Hans F. M. Pruijt, Rutger H.T. Koornstra, Otto S. Hoekstra
+4 more Gerben J.C. Zwezerijnen, Elske C. Gootjes, Henk M.W. Verheul, C. Willemien Menke‐van der Houven van Oordt
DOI: 10.1158/1078-0432.31006876
Cited by: 0

Abstract

Figure 1E Change in sum TLG after 1 dose of anti-EGFR therapy versus PFS in months. Green dots indicate patients with and red dots patients without treatment benefit after CT evaluation part 2. Grey line at data driven cut-off (part 1) of -15% change in sumTLG Figure 1F: Kaplan-Meier survival curve for PFS for metabolic non-responders (

Fields of Study & Subjects

Radiomics and Machine Learning in Medical Imaging Medical Imaging Techniques and Applications MRI in cancer diagnosis

Publication details

Publication date
6 January 2026